EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of COVID‐19 monoclonal antibodies on outcomes of COVID‐19 infection in hematopoietic stem cell transplant and chimeric antigen receptor therapy recipients

Elizabeth H Hahn iD, Hong Li, Craig S Sauter, Sherif B Mossad iD

Transplant Infectious Disease · 2024

DOI: 10.1111/tid.14322 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Elizabeth H Hahn und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, COVID-19, SARS-CoV-2, Antibodies, Monoclonal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hematopoietic stem cell transplant (HSCT) and chimeric antigen receptor T‐cell therapy (CAR‐T) recipients are at higher risk of serious complications of COVID‐19 infection than the general population. Though there is evidence that monoclonal antibodies (MCA) against COVID‐19 reduce the risk of death and hospitalization in the general population, data regarding their efficacy in HSCT and CAR‐T recipients remains scarce.

Methods

We conducted a retrospective review of HSCT and CAR‐T recipients to compare 30‐day outcomes between patients who did and did not receive MCA after their first episode of COVID‐19 between May 1, 2020 and December 31, 2022. Outcomes were defined as the most severe complication experienced out of the following: 30‐day emergency department visit, hospitalization, intensive care unit admission, and death after COVID‐19 infection.

Results

We identified 166 patients comprised of 53.6% allogeneic HSCT, 35.5% autologous HSCT, and 10.8% CAR‐T recipients; 107 had received a COVID‐19 vaccine >2 weeks prior to testing positive, and 40 were treated with MCA. After adjusting for age, presence of symptoms at the initial positive test, and COVID‐19 vaccination status, patients who did not receive MCA were five times more likely to develop complications after COVID‐19 infection (adjusted odds ratio 5.0 [95% CI, 1.9–12.8], p = .001).

Conclusion

HSCT and CAR‐T recipients who received MCA following COVID‐19 infection were far less likely to develop COVID‐related complications than those who did not receive MCA, regardless of vaccination status. This underscores the potential benefit of developing novel MCA with efficacy against circulating COVID‐19 strains. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationCOVID-19SARS-CoV-2Antibodies, MonoclonalReceptors, Chimeric AntigenHumansMaleFemaleMiddle AgedRetrospective StudiesAdultImmunotherapy, AdoptiveAgedHospitalizationTreatment OutcomeCOVID-19 Vaccines

Stichwörter der Autor:innen

CAR‐T chimeric antigen receptor T‐cell therapyCOVID‐19, coronavirus disease 2019HSCT, hematopoietic stem cell transplantMCA, monoclonal antibodies

Substanzen

Antibodies, MonoclonalReceptors, Chimeric AntigenCOVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Department of Hematology and Oncology, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Department of Infectious Disease, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

ORCID-Profile: Elizabeth H Hahn, Sherif B Mossad

Zitieren

APA

Hahn, E. H., Li, H., Sauter, C. S., & Mossad, S. B. (2024). Impact of COVID‐19 monoclonal antibodies on outcomes of COVID‐19 infection in hematopoietic stem cell transplant and chimeric antigen receptor therapy recipients. Transplant Infectious Disease. https://doi.org/10.1111/tid.14322

Vancouver

Hahn EH, Li H, Sauter CS, Mossad SB. Impact of COVID‐19 monoclonal antibodies on outcomes of COVID‐19 infection in hematopoietic stem cell transplant and chimeric antigen receptor therapy recipients. Transplant Infectious Disease. 2024. doi:10.1111/tid.14322

BibTeX
@article{Hahn2024,
  author = {Hahn, Elizabeth H and Li, Hong and Sauter, Craig S and Mossad, Sherif B},
  title = {Impact of COVID‐19 monoclonal antibodies on outcomes of COVID‐19 infection in hematopoietic stem cell transplant and chimeric antigen receptor therapy recipients},
  journal = {Transplant Infectious Disease},
  year = {2024},
  doi = {10.1111/tid.14322}
}
Kostenlos starten →